Related Experiment Videos

Central hemodynamic changes of calcium antagonists at rest and during exercise in essential hypertension

Insights

Calcium channel blockers effectively lower blood pressure and total peripheral resistance in patients with essential hypertension without compromising cardiac output. These drugs offer a promising therapeutic option for managing hypertension.

Area of Science:

  • Cardiology
  • Pharmacology
  • Hypertension Research

Background:

  • Essential hypertension is characterized by increased total peripheral resistance.
  • Calcium channel blockers are investigated for their potential to lower resistance without reducing blood flow.

Purpose of the Study:

  • To evaluate the hemodynamic effects of verapamil, nifedipine, and nisoldipine at rest and during exercise in patients with essential hypertension.
  • To assess the acute and chronic hemodynamic responses to these calcium channel blockers.

Main Methods:

  • Fifty-four patients with mild to moderate essential hypertension underwent hemodynamic studies (intra-arterial blood pressure, cardiac output) at rest and during exercise.
  • Patients received verapamil, nifedipine, or nisoldipine for 1 year, with repeat hemodynamic assessments.
  • Immediate responses to the first dose were studied for nisoldipine and placebo.

Main Results:

  • Calcium antagonists reduced blood pressure and total peripheral resistance (10-18%) without decreasing cardiac index.
  • Nisoldipine showed initial reflex tachycardia, which normalized after 1 year; verapamil reduced heart rate, compensated by increased stroke volume.
  • Total peripheral resistance decreased both acutely and chronically, with no observed depression in cardiac function.

Conclusions:

  • Verapamil, nifedipine, and nisoldipine effectively reduce total peripheral resistance in essential hypertension.
  • These calcium channel blockers maintain cardiac pump function at rest and during exercise.
  • The studied calcium channel blockers represent a viable therapeutic strategy for essential hypertension management.

Related Concept Videos